Shots
- AI is transforming clinical trial oversight from periodic monitoring to continuous, real-time intelligence, enabling early detection of safety signals, protocol deviations, and operational risks while strengthening data integrity and patient protection.
- Advanced analytics and machine learning are powering predictive, risk-based monitoring, integrating data from decentralized trials, wearables, ePROs, and multiple clinical systems to prioritize meaningful signals and optimize sponsor–CRO collaboration.
- This magazine explores how the industry is navigating the shift toward AI-enabled oversight, balancing technological innovation with governance, regulatory alignment, cybersecurity, and human expertise to ensure trustworthy and scalable clinical trial monitoring.
